Comparing the current results to its competitors, Hims And Hers Health Inc reported Revenue increase in the 2 quarter 2026 by 38.41 % year on year. The sales growth was above Hims And Hers Health Inc 's competitors' average revenue growth of 31.82 %, achieved in the same quarter.
Strong sales growth of 38.41 % in Overall company contributed to Hims and Hers Health Inc increase in total revenue by 38.41 % Hims and Hers Health Inc improved its market share in this segment, to approximately 55.26 %.
September 10, 2025
In an age where health and wellness are paramount, Hims and Hers Health, Inc. (NYSE: HIMS) is carving out a new frontier in the realm of men s health. The San Francisco-based health platform recently announced the launch of a groundbreaking category aimed at addressing low testosterone levels an ailment that afflicts an estimated twenty million men in the United States. This initiative reflects a significant step forward in providing personalized and affordable treatment options for one of the more pressing, yet often stigmatized, health concerns facing men today.Low testosterone, or hypogonadism, poses a multifaceted challenge for many men. Untreated, it can lead to fatigue, diminished mood, decreased sexua...
July 10, 2025
In the world of investment, where fortunes can rapidly dissolve into financial turmoil, the reminders of risk and caution must never be understated. Investors who once found promise in the burgeoning prospect of Hims and Hers Health, Inc. (NYSE: HIMS) a company recognized for its progressive approach to telehealth solutions now find themselves in disquieting circumstances. On July 10, 2025, Pomerantz LLP, a reputable law firm, announced the filing of a class action lawsuit against Hims and Hers. This legal development brings an alarming signal for investors who have sustained substantial losses and now stand at a critical crossroads.The allegations brought forth in the lawsuit underscore a concerning narrati...
GoodRx Holdings Inc's business model revolves around providing a platform that allows consumers to compare and access discounted prices for prescription drugs.
Lemonade Inc operates as a digital insurance company, offering homeowners and renters insurance in the United States. The business model revolves around utilizing artificial intelligence and chatbots to provide instant and personalized coverage, while leveraging a flat fee structure and giving back unclaimed premiums to causes chosen by customers.
Mangoceuticals Inc's business model focuses on producing and selling products that harness the beneficial properties of mangoes, potentially in the field of skincare or healthcare.
Marpai Inc. operates under a subscription-based business model, providing customers with access to an online platform that offers various educational courses and tutorials. The company generates revenue by charging users a monthly or annual fee for accessing their content, allowing customers to enhance their skillset and gain knowledge in a wide range of subjects. Marpai Inc. retains customers through regular updates and new course offerings, ensuring continued engagement and value for their subscribers.
Sources:
Hims and Hers Health Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Hims and Hers Health Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
